Avenue Therapeutics to Participate in Upcoming Investor Conferences
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 03 2024
0mins
Source: Newsfilter
Upcoming Investor Conferences: Avenue Therapeutics CEO Alexandra MacLean will participate in the H.C. Wainwright 26th Annual Global Investment Conference on September 9, 2024, and the Lake Street Capital Markets BIG8 Conference on September 12, 2024, both held in New York.
Company Overview: Avenue Therapeutics is focused on developing therapies for neurologic diseases, with three key assets in development, including treatments for spinal and bulbar muscular atrophy and acute postoperative pain management.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.





